Veradermics, Incorporated
MANEStock
$105.83
Market Cap$4.60B
P/E—
Div yield—
Beta-0.90
Price Chart
Favorite Metrics
Price vs S&P 500 (4W)14.84%
VGM Score70.63
Market Capitalization$4.60B
Earnings Surprise History
Q1 26-1.32est. -0.67
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.40
4.40
4.40
4.33
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MANEVeradermics, Incorporated | — | — | B | $105.83 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Veradermics Inc is a clinical-stage biopharmaceutical company developing therapeutics for aesthetic and dermatological conditions. The company addresses treatment gaps in high-prevalence skin disorders with novel therapeutic approaches.